Concord Medical Services Holdings Limited
CCM
$7.81
-$0.39-4.76%
NYSE
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 76.06M | 88.11M | 78.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 76.06M | 88.11M | 78.73M |
| Cost of Revenue | -- | -- | 86.89M | 102.65M | 97.31M |
| Gross Profit | -- | -- | -10.82M | -14.54M | -18.58M |
| SG&A Expenses | -- | -- | 54.52M | 56.45M | 55.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 141.40M | 159.10M | 153.03M |
| Operating Income | -- | -- | -65.34M | -70.99M | -74.31M |
| Income Before Tax | -- | -- | -78.27M | -115.23M | -119.13M |
| Income Tax Expenses | -- | -- | -3.54M | -12.16M | -11.22M |
| Earnings from Continuing Operations | -- | -- | -74.73 | -103.06 | -107.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 33.00M | 36.14M | 38.79M |
| Net Income | -- | -- | -41.72M | -66.92M | -69.11M |
| EBIT | -- | -- | -65.34M | -70.99M | -74.31M |
| EBITDA | -- | -- | -48.08M | -54.31M | -58.45M |
| EPS Basic | -- | -- | -286.52 | -459.59 | -474.60 |
| Normalized Basic EPS | -- | -- | -2.74 | -1.87 | -1.87 |
| EPS Diluted | -- | -- | -287.05 | -460.22 | -475.23 |
| Normalized Diluted EPS | -- | -- | -2.74 | -1.87 | -1.87 |
| Average Basic Shares Outstanding | -- | -- | 17.47M | 17.47M | 17.47M |
| Average Diluted Shares Outstanding | -- | -- | 582.40K | 582.40K | 582.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |